MiNK Therapeutics(INKT) - 2025 Q1 - Quarterly Report

WASHINGTON, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION MiNK Therapeutics, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 82-2142067 (State or other jurisdiction of incorporation or organization) 149 Fifth Avenue (I.R.S. Employer Identification No.) Suite 500 New York, NY 10010 (Address of principal executive offices) (Zip Code) ...